Price $74.19 |
Market Cap
10.64B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
18.5
|
P/B
3.28
|
P/S
0.93
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
14.6
|
Op. Cash Flow
820.9K
|
FCF
5.3
|
|
Op. Margin
6.80%
|
Net Margin
5.10%
|
ROE
18.30%
|
ROI
10.90%
|
|
ROA
7.70%
|
EPS Growth
5.30%
|
Current Ratio
1.7
|
Debt/Equity
15.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $27.76 | - | - | 10B | Strong Buy |
| Recro Pharma Inc (REPH) | $1.90 | - | - | 95.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $7.01 | - | - | 284.5M | Strong Buy |
| Rigel Pharmaceuticals, Inc. (RIGL) | $3.27 | - | - | 620.2M | Strong Buy |
| La Jolla Pharmaceutical Compan (LJPC) | $3.85 | - | - | 109.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
